These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33190085)

  • 21. Real-life use of budesonide/formoterol in clinical practice: a 12-month follow-up assessment in a multi-national study of asthma patients established on single-inhaler maintenance and reliever therapy.
    Ställberg B; Naya I; Ekelund J; Eckerwall G
    Int J Clin Pharmacol Ther; 2015 Jun; 53(6):447-55. PubMed ID: 25907171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation.
    Miller E; FitzGerald JM
    Can J Clin Pharmacol; 2008; 15(2):e165-76. PubMed ID: 18515918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A health-related quality-of-life comparison of formoterol (Oxis) Turbuhaler plus budesonide (Pulmicort) Turbuhaler with budesonide Turbuhaler alone and noncorticosteroid treatment in asthma: a randomized clinical study in Russia.
    Chuchalin AG; Svensson K; Ståhl E; Ovcharenko SI; Goriachkina LA; Sidorenko IV; Tsoi AN;
    Respiration; 2002; 69(5):427-33. PubMed ID: 12232450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial.
    Papi A; Marku B; Scichilone N; Maestrelli P; Paggiaro P; Saetta M; Nava S; Folletti I; Bertorelli G; Bertacco S; Contoli M; Plebani M; Barbaro MPF; Spanevello A; Aliani M; Pannacci M; Morelli P; Beghé B; Fabbri LM;
    Lancet Respir Med; 2015 Feb; 3(2):109-119. PubMed ID: 25481378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Budesonide/formoterol maintenance and reliever therapy in asthma control: acute, dose-related effects and real-life effectiveness.
    Lin CH; Hsu JY; Hsiao YH; Tseng CM; Su VY; Chen YH; Yang SN; Lee YC; Su KC; Perng DW
    Respirology; 2015 Feb; 20(2):264-72. PubMed ID: 25366969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) for the treatment of asthma.
    Rosenhall L; Elvstrand A; Tilling B; Vinge I; Jemsby P; Ståhl E; Jerre F; Bergqvist PB
    Respir Med; 2003 Jun; 97(6):702-8. PubMed ID: 12814158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma.
    O'Byrne PM; FitzGerald JM; Bateman ED; Barnes PJ; Zhong N; Keen C; Jorup C; Lamarca R; Ivanov S; Reddel HK
    N Engl J Med; 2018 May; 378(20):1865-1876. PubMed ID: 29768149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.
    Atienza T; Aquino T; Fernández M; Boonsawat W; Kawai M; Kudo T; Ekelund J; Ivanov S; Carlsson LG
    Respirology; 2013 Feb; 18(2):354-63. PubMed ID: 23126237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial.
    Pavord ID; Holliday M; Reddel HK; Braithwaite I; Ebmeier S; Hancox RJ; Harrison T; Houghton C; Oldfield K; Papi A; Williams M; Weatherall M; Beasley R;
    Lancet Respir Med; 2020 Jul; 8(7):671-680. PubMed ID: 32171064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial.
    Baggott C; Reddel HK; Hardy J; Sparks J; Holliday M; Corin A; Montgomery B; Reid J; Sheahan D; Hancox RJ; Weatherall M; Beasley R; Fingleton J;
    Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 32029450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma.
    Bateman ED; Bantje TA; João Gomes M; Toumbis MG; Huber RM; Naya I; Eliraz A
    Am J Respir Med; 2003; 2(3):275-81. PubMed ID: 14720008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma.
    Beasley R; Harper J; Bird G; Dunphy H; Semprini A; Pavord ID; Papi A; Weatherall M
    BMC Pulm Med; 2019 Dec; 19(1):264. PubMed ID: 31883519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study.
    O'Byrne PM; FitzGerald JM; Bateman ED; Barnes PJ; Zheng J; Gustafson P; Lamarca R; Puu M; Keen C; Alagappan VKT; Reddel HK
    Lancet Respir Med; 2021 Feb; 9(2):149-158. PubMed ID: 33010810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines.
    Lin J; Zhou X; Wang C; Liu C; Cai S; Huang M
    Expert Rev Respir Med; 2018 Mar; 12(3):191-202. PubMed ID: 29400090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma.
    Bisgaard H; Le Roux P; Bjåmer D; Dymek A; Vermeulen JH; Hultquist C
    Chest; 2006 Dec; 130(6):1733-43. PubMed ID: 17166990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
    Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter, cross-sectional, observational study of budesonide/formoterol maintenance and reliever therapy in real-world settings.
    Lin J; Li J; Yu W; Liu Y; Liu C; Chen P; He H; He B; Liu S; Zhou X
    Respir Med; 2017 Jun; 127():45-50. PubMed ID: 28502418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma.
    Ställberg B; Ekström T; Neij F; Olsson P; Skoogh BE; Wennergren G; Löfdahl CG;
    Respir Med; 2008 Oct; 102(10):1360-70. PubMed ID: 18723335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.